1-Methyl-4-(nonyloxy)benzene | 61343-79-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-Methyl-4-(nonyloxy)benzene
• 英文别名: 1-methyl-4-nonoxybenzene
• CAS: 61343-79-1
• 化学式: C₁₆H₂₆O
• mdl: MFCD20109192
• 分子量: 234.38
• InChiKey: DUIKERDOPOPXBD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.4
• 重原子数：
  17
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.625
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Antibacterial agent and therapeutic agent for Johne's disease containing the same
  申请人：Takahashi Yoshiaki

  公开号：US20090209744A1

  公开（公告）日：2009-08-20

  An antibacterial agent having high antibacterial activity against Mycobacterium avium subsp. paratuberculosis is provided. Specifically, the antibacterial agent of the present invention having high antibacterial activity against Mycobacterium avium subsp. paratuberculosis is a caprazamycin derivative represented, for example, by the following general formula (II): wherein Me is a methyl group; and R 1 is a straight or substantially straight chain alkyl group having 5 to 21 carbon atoms, a straight or substantially straight chain alkenyl group having 5 to 21 carbon atoms, a cycloalkyl group having 5 to 12 carbon atoms, or a phenyl group substituted at the para-position with a straight chain alkyl group having 1 to 14 carbon atoms, a straight chain alkoxy group having 1 to 9 carbon atoms or a cycloalkyl group having 5 to 12 carbon atoms.

  提供了一种对鲁氏分枝杆菌亚种鲁氏分枝杆菌具有高抗菌活性的抗菌剂。具体来说，本发明的抗菌剂对鲁氏分枝杆菌亚种鲁氏分枝杆菌具有高抗菌活性，例如由以下通用公式（II）表示的卡普拉霉素衍生物：其中Me是一个甲基基团；而R1是一个由5至21个碳原子组成的直链或几乎直链烷基基团，由5至21个碳原子组成的直链或几乎直链烯基基团，由5至12个碳原子组成的环烷基基团，或者在对位上用具有1至14个碳原子的直链烷基基团、具有1至9个碳原子的直链烷氧基基团或由5至12个碳原子组成的环烷基基团取代的苯基团。
• [EN] A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION D'INTERMÉDIAIRES DE TRIAZINE ET PROCÉDÉ DE PRÉPARATION D'ABSORBEURS UV ASSOCIÉS
  申请人：BASF SE

  公开号：WO2020144093A1

  公开（公告）日：2020-07-16

  The presently claimed invention relates to a novel, highly efficient and general process for the preparation of the triazine intermediates and their use in the preparation of UV absorbers.

  目前所声称的发明涉及一种新颖、高效和通用的三嗪中间体制备过程及其在制备紫外线吸收剂中的应用。
• CAPRAZENE AS A NOVEL COMPOUND AND DERIVATIVES THEREOF, AND CAPRAZOL AS A NOVEL COMPOUND AND DERIVATIVES THEREOF
  申请人：MIYAKE Toshiaki

  公开号：US20090131652A1

  公开（公告）日：2009-05-21

  Caprazene and caprazol could be synthesized by hydrolysis of a caprazamycin. There could be synthesized a caprazene-1′″-amide derivative of the formula (II) and a caprazene-1′″-ester derivative of the formula (III) from caprazene. Further, there could be synthesized a caprazol-1′″-amide derivative of the formula (V) and a caprazol-1′″-amide-3′″-ester derivative and a caprazol-3′″-ester derivative, etc. from caprazol. Furthermore, an imidazolidinone derivative could be synthesized from the ring-opened product of the 1,4-diazepinone ring of caprazol. The novel caprazene derivative, novel caprazol derivative and novel imidazolidinone derivative now synthesized exhibit excellent antibacterial activities against a variety of bacteria, including acid-fast bacteria.

  Caprazene和caprazol可以通过水解caprazamycin来合成。可以从caprazene合成公式（II）的caprazene-1'″-酰胺衍生物和公式（III）的caprazene-1'″-酯衍生物。此外，可以从caprazol合成公式（V）的caprazol-1'″-酰胺衍生物，caprazol-1'″-酰胺-3'″-酯衍生物和caprazol-3'″-酯衍生物等。此外，可以从caprazol的1,4-二氮杂环酮环的开环产物合成咪唑啉酮衍生物。现在合成的新型caprazene衍生物，新型caprazol衍生物和新型咪唑啉酮衍生物对各种细菌，包括抗酸菌，表现出优异的抗菌活性。
• Composition, article and their production method, and film and its production method
  申请人：Fujifilm Corporation

  公开号：EP2025711A1

  公开（公告）日：2009-02-18

  A composition comprising an organic crystal having a minor axis length of from 3 to 100 nm and a major axis length of from 10 to 2, 000 nm and a matrix material, wherein the organic crystal satisfies that (1) a surfactant is adsorbed on the organic crystal, (2) an inorganic ion is adsorbed on the organic crystal, (3) silicon oxide, titanium oxide, aluminum oxide, zirconium oxide, barium oxide or hydroxyapatite is bonded with the organic crystal, or (4) the organic crystal is modified with a group represented by the following formula (1): wherein L1 represents -O-, -S-, -CO- or others, n is 0 to 4, and R1 represents an organic group.

  一种组合物，包括小轴长度为3至100纳米、大轴长度为10至2000纳米的有机晶体和基体材料，其中有机晶体满足以下条件：(1) 有机晶体上吸附有表面活性剂；(2) 有机晶体上吸附有无机离子；(3) 氧化硅、氧化钛、氧化铝、氧化锆、氧化钡或羟基磷灰石与基体材料结合、(2) 有机晶体上吸附了无机离子； (3) 有机晶体上粘结了氧化硅、氧化钛、氧化铝、氧化锆、氧化钡或羟基磷灰石；或 (4) 有机晶体被下式(1)所代表的基团修饰： 其中 L1 代表-O-、-S-、-CO-或其他，n 为 0 至 4，R1 代表有机基团。
• POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION
  申请人：Asahi Kasei Chemicals Corporation

  公开号：EP2915803A1

  公开（公告）日：2015-09-09

  The present invention relates to a polyisocyanate composition comprising, on the basis of the total mass of the polyisocyanate composition, 97 weight % or more of a polyisocyanate, and 2.0 mass ppm or more and 1.0×104 mass ppm or less of a compound having at least one unsaturated bond in which the compound is a different compound from the polyisocyanate, or 5.0 mass ppm or more and 2.0×104 mass ppm or less of at least one inactive compound selected from the group consisting of a hydrocarbon compound, an ether compound, a sulfide compound, a halogenated hydrocarbon compound, a Si-containing hydrocarbon compound, a Si-containing ether compound, and a Si-containing sulfide compound.

  本发明涉及一种多异氰酸酯组合物，以该多异氰酸酯组合物的总质量为基准，该组合物包含 97 重量％或以上的多异氰酸酯，以及 2.0 质量 ppm 或以上且 1.0×104 质量 ppm 或以下的至少具有一个不饱和键的化合物，其中该化合物是与多异氰酸酯不同的化合物，或 5.0 质量 ppm 或以上且 2.0×104 质量 ppm 或以下的至少一种非活性化合物，该化合物选 自烃化合物、醚化合物、硫化物化合物、卤代烃化合物、含硅烃化合物、含硅醚化合物和含硅硫 化物组成的组。